| RS281865497 |
TK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS281865498 |
TK2
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS281865499 |
TK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial DNA depletion syndrome, Mitochondrial disease |
| RS281865500 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome, myopathic form |
| RS281865501 |
TK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial DNA depletion syndrome, myopathic form |
| RS281865502 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome, myopathic form |
| RS281865503 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS281865504 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS281865505 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS281865506 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS281865507 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome, Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS281865514 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS281865515 |
CRX
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 7, Leber congenital amaurosis 7 |
| RS281865516 |
CRX
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 2, Leber congenital amaurosis 7 |
| RS281865517 |
CRX
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 7, Leber congenital amaurosis 7 |
| RS281865520 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS281865522 |
TYR
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 1A, SKIN/HAIR/EYE PIGMENTATION 3 |
| RS281865524 |
TYR
|
Health Risk |
Pathogenic |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN |
| RS281865526 |
TYR
|
Health Risk |
Pathogenic |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN |
| RS281865527 |
TYR
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 1A, Inborn genetic diseases |
| RS281865528 |
BEST1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 2, Retinal dystrophy |
| RS281865529 |
BEST1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS281865530 |
BEST1
|
Health Risk |
Pathogenic |
— |
| RS281865531 |
BEST1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS281865532 |
BEST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS281865547 |
WRAP53
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 3 |
| RS281865548 |
WRAP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 3 |
| RS281865549 |
WRAP53
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 3 |
| RS281865550 |
WRAP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 3 |
| RS281865552 |
OTC
|
Health Risk |
Pathogenic/Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Thyroid cancer |
| RS281865554 |
OTC
|
Health Risk |
Likely pathogenic |
Nonpapillary renal cell carcinoma, Ornithine carbamoyltransferase deficiency |
| RS281865555 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN I (BURLINGTON), HEMOGLOBIN I (PHILADELPHIA) |
| RS281865557 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS281865560 |
HBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281865564 |
PRICKLE1
|
Health Risk |
Pathogenic |
Epilepsy, progressive myoclonic |
| RS281874656 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874658 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874659 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874663 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874664 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874667 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874668 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874669 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874670 |
COL4A5
|
Health Risk |
Pathogenic |
Alport syndrome, X-linked Alport syndrome |
| RS281874671 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874673 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, Alport syndrome |
| RS281874674 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874675 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874676 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874680 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874681 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS281874683 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874684 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874688 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, Nonpapillary renal cell carcinoma |
| RS281874689 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874692 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874696 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874697 |
COL4A5
|
Health Risk |
Pathogenic |
COL4A5-related disorder, X-linked Alport syndrome |
| RS281874699 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874702 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874703 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874706 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874709 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874712 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874713 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, COL4A5-related disorder |
| RS281874715 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874717 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874721 |
COL4A5
|
Health Risk |
Pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS281874722 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874723 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874724 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874725 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS281874727 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874734 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, Thyroid cancer |
| RS281874735 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874738 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874739 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS281874741 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874743 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, Hearing impairment |
| RS281874747 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, Alport syndrome |
| RS281874750 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874753 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, Alport syndrome |
| RS281874755 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874759 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874760 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS281874761 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874763 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, Alport syndrome |
| RS281874765 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874768 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS281874770 |
STAT2
|
Health Risk |
Pathogenic |
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection, Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection |
| RS281875168 |
SERPING1
|
Health Risk |
Likely pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS281875170 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Malignant tumor of urinary bladder |
| RS281875171 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS281875174 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema with C1Inh deficiency |
| RS281875178 |
SERPING1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS281875184 |
SMARCA2
|
Health Risk |
Pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS281875185 |
SMARCA2
|
Health Risk |
Pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS281875186 |
SMARCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS281875187 |
SMARCA2
|
Health Risk |
Pathogenic |
Nicolaides-Baraitser syndrome, SMARCA2-related BAFopathy |
| RS281875188 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, SMARCA2-related BAFopathy |